Author: Dorron Blumberg

TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXYTM (estradiol vaginal inserts), the Lowest Dose Vaginal Estrogen Product Approved for the Treatment of Moderate to Severe Dyspareunia, a Symptom of VVA, due to Menopause

BOCA RATON, Fla.-TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that the United States Food and Drug Administration (FDA) has approved IMVEXXYTM (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia (vaginal pain associated with sexual activity), a symptom of vulvar and vaginal atrophy (VVA), due to menopause. IMVEXXY is the only product in its therapeutic class to offer a 4 mcg and 10 mcg dose, the 4 mcg representing the lowest approved dose of vaginal estradiol available.

Read More

Florida Ban On Smokable Medical Pot Ruled Unconstitutional

By The Associated Press • May 29, 2018 
 
Florida’s ban that prevents medical marijuana patients from smoking their cannabis has gone up in smoke.
 
Leon County Circuit Court Judge Karen Gievers on Friday ruled that a state’s ban on smokable cannabis is unconstitutional. Florida’s Department of Health said in a statement it has appealed the ruling, which will impose an automatic stay.
 
Gievers wrote in her 22-page ruling that Floridians "have the right to use the form of medical marijuana for treatment of their debilitating medical conditions as recommended by their certified physicians, including the use of smokable marijuana in private places."
 
Ben Pollara, who runs the nonprofit medical marijuana advocacy group Florida for Care, said the ruling is a big victory for patients and voters.
 
Taylor Patrick Biehl of the Medical Marijuana Business Association of Florida added that "despite legislative pushback over interpretation and ideologies, justice has been served."
 

Read More

MediXall Group, Inc. Launches New Flexible Patient Financing Solution

MediXall Group Inc., (OTCQB: MDXL), a technology and innovation-driven organization structured to bring effective change to the U.S. Healthcare Industry, announced today the launch of MediXall Finance Group, a new flexible patient financing program to address traditional deductibles and high out-of-pocket expenses that patients face today, including those for services in elective markets, such as dentists, audiologists and surgeons in cosmetic, eye, orthopedic and other specialties. 

Read More